{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T09:55:54Z","timestamp":1758189354268,"version":"3.44.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,16]]},"DOI":"10.7759\/cureus.92483","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T01:40:19Z","timestamp":1758073219000},"source":"Crossref","is-referenced-by-count":0,"title":["An Unusual Case of Primary Plasma Cell Leukemia Presenting As Pericardial Effusion"],"prefix":"10.7759","author":[{"given":"Ahmed","family":"Qaedi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ethan","family":"Barnes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Hachem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farrah","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2023.2254556","article-title":"Clinical and cytogenetic characteristics of primary and secondary plasma cell leukemia under the new IMWG definition criteria: a retrospective study","volume":"28","author":"Guan J","year":"2023","unstructured":"Guan J, Ma J, Chen B. Clinical and cytogenetic characteristics of primary and secondary plasma cell leukemia under the new IMWG definition criteria: a retrospective study. Hematology. 2023, 28:2254556. 10.1080\/16078454.2023.2254556","journal-title":"Hematology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.133.5.813","article-title":"Plasma cell leukemia. Report on 17 cases","volume":"133","author":"Kyle RA","year":"1974","unstructured":"Kyle RA, Maldonado JE, Bayrd ED. Plasma cell leukemia. Report on 17 cases. Arch Intern Med. 1974, 133:813-8. 10.1001\/archinte.133.5.813","journal-title":"Arch Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00587-0","article-title":"Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage","volume":"11","author":"Fern\u00e1ndez de Larrea C","year":"2021","unstructured":"Fern\u00e1ndez de Larrea C, Kyle R, Rosi\u00f1ol L, et al.. Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage. Blood Cancer J. 2021, 11:192. 10.1038\/s41408-021-00587-0","journal-title":"Blood Cancer J"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2991\/chi.k.200706.002","article-title":"Plasma cell leukemia - facts and controversies: more questions than answers?","volume":"2","author":"Suska A","year":"2020","unstructured":"Suska A, Vesole DH, Castillo JJ, et al.. Plasma cell leukemia - facts and controversies: more questions than answers?. Clin Hematol Int. 2020, 2:133-42. 10.2991\/chi.k.200706.002","journal-title":"Clin Hematol Int"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V93.3.1032.403a15_1032_1037","article-title":"Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics","volume":"93","author":"Garc\u00eda-Sanz R","year":"1999","unstructured":"Garc\u00eda-Sanz R, Orf\u00e3o A, Gonz\u00e1lez M, et al.. Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristics. Blood. 1999, 93:1032-1037. 10.1182\/blood.V93.3.1032.403a15_1032_1037","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10585-007-9108-4","article-title":"Extravasation and homing mechanisms in multiple myeloma","volume":"25","author":"Vande Broek I","year":"2008","unstructured":"Vande Broek I, Vanderkerken K, Van Camp B, Van Riet I. Extravasation and homing mechanisms in multiple myeloma. Clin Exp Metastasis. 2008, 25:325-34. 10.1007\/s10585-007-9108-4","journal-title":"Clin Exp Metastasis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-021-00414-6","article-title":"A clinical perspective on plasma cell leukemia; current status and future directions","volume":"11","author":"Tuazon SA","year":"2021","unstructured":"Tuazon SA, Holmberg LA, Nadeem O, Richardson PG. A clinical perspective on plasma cell leukemia; current status and future directions. Blood Cancer J. 2021, 11:23. 10.1038\/s41408-021-00414-6","journal-title":"Blood Cancer J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24954","article-title":"Efficacy of VDT PACE-like regimens in treatment of relapsed\/refractory multiple myeloma","volume":"93","author":"Lakshman A","year":"2018","unstructured":"Lakshman A, Singh PP, Rajkumar SV, et al.. Efficacy of VDT PACE-like regimens in treatment of relapsed\/refractory multiple myeloma. Am J Hematol. 2018, 93:179-86. 10.1002\/ajh.24954","journal-title":"Am J Hematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-02-268862","article-title":"Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma","volume":"116","author":"Richardson PG","year":"2010","unstructured":"Richardson PG, Weller E, Lonial S, et al.. Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma. Blood. 2010, 116:679-86. 10.1182\/blood-2010-02-268862","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)31240-1","article-title":"Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study [published correction appears in","volume":"1016","author":"Moreau P","year":"2024","unstructured":"Moreau P, Attal M, Hulin C, et al.. Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study [published correction appears in. Lancet. 2024, 1016:29-38. 10.1016\/S0140-6736(19)31240-1","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00428-9","article-title":"Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial","volume":"22","author":"Moreau P","year":"2021","unstructured":"Moreau P, Hulin C, Perrot A, et al.. Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial. Lancet Oncol. 2021, 22:1378-1390. 10.1016\/S1470-2045(21)00428-9","journal-title":"Lancet Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq646","article-title":"Primary plasma cell leukemia: a retrospective multicenter study of 73 patients","volume":"22","author":"Pagano L","year":"2011","unstructured":"Pagano L, Valentini CG, De Stefano V, et al.. Primary plasma cell leukemia: a retrospective multicenter study of 73 patients. Ann Oncol. 2011, 22:1628-35. 10.1093\/annonc\/mdq646","journal-title":"Ann Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1177\/10815589251339688","article-title":"An unusual case of plasma cell leukemia presenting as malignant pericardial effusion. American Federation for Medical Research 2025 Southeastern Regional Meeting","volume":"73","author":"Qaedi A","year":"2025","unstructured":"Qaedi A, Barnes E, Hachem A, Ibrahim F. An unusual case of plasma cell leukemia presenting as malignant pericardial effusion. American Federation for Medical Research 2025 Southeastern Regional Meeting. Journal of Investigative Medicine. 2025, 73:1-41. 10.1177\/10815589251339688","journal-title":"Journal of Investigative Medicine"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31718","article-title":"Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agents","volume":"125","author":"Mina R","year":"2019","unstructured":"Mina R, Joseph NS, Kaufman JL, et al.. Survival outcomes of patients with primary plasma cell leukemia (pPCL) treated with novel agents. Cancer. 2019, 125:416-23. 10.1002\/cncr.31718","journal-title":"Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-233340","article-title":"Pericardial relapse of multiple myeloma","volume":"13","author":"Jamison LS","year":"2020","unstructured":"Jamison LS, Mo CC, Kwok M. Pericardial relapse of multiple myeloma. BMJ Case Rep. 2020, 13:10.1136\/bcr-2019-233340","journal-title":"BMJ Case Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2019.11.034","article-title":"Rapidly progressive atrial mass and cardiac tamponade: a rare presentation of multiple myeloma","volume":"2","author":"Kashyap JR","year":"2020","unstructured":"Kashyap JR, Tahlan A, Kumar S, Reddy S, Kundu R. Rapidly progressive atrial mass and cardiac tamponade: a rare presentation of multiple myeloma. JACC Case Rep. 2020, 2:279-81. 10.1016\/j.jaccas.2019.11.034","journal-title":"JACC Case Rep"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpath.2019.02.002","article-title":"A plasma cell-based pericardial effusion leading to tamponade in a patient with multiple myeloma - a case report and review of the literature","volume":"40","author":"Skipina TM","year":"2019","unstructured":"Skipina TM, Sane DC, Cui C, Song S, Phillips SG, Jarrett RW. A plasma cell-based pericardial effusion leading to tamponade in a patient with multiple myeloma - a case report and review of the literature. Cardiovasc Pathol. 2019, 40:41-6. 10.1016\/j.carpath.2019.02.002","journal-title":"Cardiovasc Pathol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2025.01.022","article-title":"European Myeloma Network Group review and consensus statement on primary plasma cell leukemia","volume":"36","author":"Musto P","year":"2025","unstructured":"Musto P, Engelhardt M, van de Donk NW, et al.. European Myeloma Network Group review and consensus statement on primary plasma cell leukemia. Ann Oncol. 2025, 36:361-74. 10.1016\/j.annonc.2025.01.022","journal-title":"Ann Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/410701-an-unusual-case-of-primary-plasma-cell-leukemia-presenting-as-pericardial-effusion","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T01:40:20Z","timestamp":1758073220000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/410701-an-unusual-case-of-primary-plasma-cell-leukemia-presenting-as-pericardial-effusion"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,16]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.92483","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9,16]]}}}